Schedule 13G ownership disclosure

Lipocine Inc

Common Stock, par value $0.0001 per share · CUSIP: 53630X203

Event date: 2025-12-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 444,632.00 · Class: 8.0%

  • Squadron Capital Management LLC

    Shares: 500,000.00 · Class: 9.0%

  • Matthew Sesterhenn

    Shares: 500,000.00 · Class: 9.0%

  • William Blank

    Shares: 500,000.00 · Class: 9.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-25-000012
Form type
SCHEDULE 13G
Filer
Lipocine Inc.
CIK
CIK 1535955
Filed
Dec 23, 2025
Reporting period
Dec 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub